Medication & supplement lookup.

A proprietary fatty-acid supplement marketed as 1-TDC for oral and mobility support in dogs and cats. It is a support product rather than a generic drug, and manufacturer marketing should not be mistaken for a complete independent efficacy assessment.

A phenothiazine tranquilizer that produces sedation and reduces spontaneous activity. PromAce is an identifiable brand; clinical selection depends on patient status, other sedatives and the planned procedure.

A stool-consistency and gastrointestinal support product. The manufacturer describes an adsorbent/demulcent preparation and supplies a supplement-style FDA disclaimer; it should not be presented as an FDA-approved cure for diarrhea.

An isoxazoline ectoparasiticide in NexGard chewables for dogs. The single-ingredient product is used for labeled flea and tick control; its coverage should not be confused with a similarly named combination preventative.

A calcium-channel blocker that lowers blood pressure by relaxing arterial smooth muscle. Amodip is a feline veterinary product; Norvasc is a human formulation whose veterinary use is extra-label. Product selection and monitoring require patient-specific blood-pressure assessment.

Amoxicillin is a penicillin-class antibiotic for susceptible bacteria. The veterinary Amoxi products and human Amoxil share an active drug, but their labels and presentations must still be reconciled when prescribing or dispensing.

This combination pairs a penicillin antibiotic with a beta-lactamase inhibitor. Veterinary Clavamox and Clavacillin are used for specified infections involving susceptible organisms; adding clavulanate does not make every resistant organism treatable.

A canine monoclonal antibody that binds nerve growth factor, used to control pain associated with osteoarthritis in dogs. It is an injectable biologic, rather than an NSAID or joint supplement.

An angiotensin-converting enzyme (ACE) inhibitor. Lotensin is a human prescription product labeled for hypertension; use of this human product in veterinary patients is extra-label and requires a veterinarian’s treatment plan.

Bexagliflozin is an SGLT2 inhibitor that increases urinary glucose loss. Bexacat is labeled for otherwise healthy diabetic cats that have not previously received insulin; it is not an oral replacement for insulin in every diabetic patient.

An opioid analgesic. Zorbium is a transdermal buprenorphine product labeled for control of postoperative pain in cats.

A ghrelin-receptor agonist with two distinct veterinary oral products: Entyce for appetite stimulation in dogs and Elura for managing weight loss in cats with chronic kidney disease.

A nonsteroidal anti-inflammatory drug for pain and inflammation. Rimadyl labeling covers osteoarthritis and postoperative pain in dogs.

Cefovecin is a long-acting cephalosporin antibiotic. Convenia’s US label covers specified susceptible skin infections in dogs and cats; injection convenience is not evidence that it is the best antibiotic for every infection.

An oral cephalosporin prodrug converted to cefpodoxime. Simplicef is labeled for susceptible bacterial skin infections, including wounds and abscesses, in dogs.

A first-generation cephalosporin antibacterial. Rilexine is a canine veterinary product and Keflex is a human product. Infection site, organism, formulation and clinical status determine the appropriate prescribing plan.

An H1 antihistamine. The cited Zyrtec product is a human oral allergy medicine; animal use requires a veterinarian to select the product and assess whether an antihistamine fits the condition.

Chlorpheniramine is a first-generation antihistamine. Chlor-Trimeton is a human brand-name reference; veterinary use requires a species-specific prescribing decision rather than following the human package directions.

A first-generation antihistamine. Tavist and Tavist Allergy are human brand names associated with clemastine; these names do not establish veterinary approval.

Clomipramine is a tricyclic antidepressant. Clomicalm is labeled as part of a canine separation-anxiety treatment plan that includes behavior modification; it is not a general treatment for every unwanted behavior.

Exact product and active ingredients require confirmation. A cough-product name alone does not establish its formulation, safety, therapeutic use or equivalent brands.

Cyclosporine modifies immune activity. Atopica’s dog and cat products are labeled for their respective allergic skin diseases; different clinical uses require an individual prescribing assessment.

A canine nonsteroidal anti-inflammatory drug used for osteoarthritis pain and inflammation and specified postoperative orthopedic or dental indications. The clinical indication determines which label instructions apply.

A long-acting mineralocorticoid replacement used in dogs with primary hypoadrenocorticism (Addison’s disease). It supports sodium and potassium regulation but does not replace glucocorticoid therapy when the dog also has that deficiency.

An alpha-2 agonist. Sileo is a dexmedetomidine oromucosal gel labeled for noise aversion in dogs.

A tetracycline-class antibacterial. Vibramycin is a human brand family containing doxycycline in several salt and oral formulations.

A combination dewormer. The U.S. Profender product is a topical solution for cats targeting labeled intestinal worms; it is not simply another brand of praziquantel alone.

An angiotensin-converting enzyme inhibitor identified by the brands Vasotec and historical canine Enacard. Clinical use requires a patient-specific assessment of cardiovascular status, renal function and other medications.

Enrofloxacin is a fluoroquinolone antibiotic for susceptible bacterial pathogens. The referenced Baytril Taste Tabs label applies to dogs and cats; a brand-family search should not be taken as authorization for a different formulation or species.

A macrolide antibiotic. This entry covers sterile erythromycin ophthalmic ointment for susceptible superficial ocular infections; systemic products are separate formulations.

An estrogen used in Incurin to control estrogen-responsive urinary incontinence in spayed female dogs. It is not a general treatment for urinary accidents of any cause.

A histamine-2 receptor antagonist that reduces gastric acid secretion. Pepcid and Pepcid AC are human famotidine products; veterinary use is extra-label and should follow the veterinarian’s assessment of the reason for acid suppression.

A benzimidazole anthelmintic supplied under Panacur in several species-specific formulations. Parasite claims depend on the formulation and labeled species; one product name does not establish coverage for every intestinal parasite.

A coxib-class NSAID. Previcox is a canine chewable product labeled for osteoarthritis pain and inflammation and specified postoperative pain; species and formulation identification are essential before selecting a treatment plan.

A triazole antifungal. Selecting it requires identifying the likely organism and infection site; a fungal diagnosis does not make all azole medications equivalent.

A corticosteroid with strong mineralocorticoid activity, identified in human replacement-therapy labeling. Veterinary replacement plans require the clinician to assess electrolyte balance and the full hormone needs of the patient.

A corticosteroid–DMSO ear solution identified by Synotic. The label covers relief of itching and inflammation associated with acute or chronic otitis in dogs; it does not supply an antibiotic ingredient.

A selective serotonin reuptake inhibitor used in behavioral treatment. Reconcile is labeled for canine separation anxiety together with a behavior modification plan.

Fluralaner is an isoxazoline parasiticide. Single-ingredient Bravecto presentations control labeled fleas and ticks, but duration, route, age requirements and tick claims depend on the exact product.

A feline monoclonal antibody targeting nerve growth factor. Solensia is labeled to control pain associated with osteoarthritis in cats.

A loop diuretic used to increase urinary salt and water loss. Lasix is a human furosemide brand; veterinary treatment requires assessing the cause of fluid accumulation and the patient’s circulation and kidney status.

A nervous-system medication with human labeling for postherpetic neuralgia and adjunctive partial-onset seizure treatment. Neurontin is a human brand; veterinary use is extra-label and the prescriber must specify the goal, formulation and monitoring.

An antibiotic–corticosteroid–antifungal combination identified by Otomax. The label addresses canine otitis externa associated with susceptible bacteria and/or yeast; selection should follow ear examination and appropriate organism assessment.

An EP4 prostaglandin-receptor antagonist, classified in labeling as a non-COX-inhibiting NSAID. Galliprant is labeled to control osteoarthritis pain and inflammation in dogs.

A corticosteroid available in multiple formulations. This entry covers a human-labeled topical anti-itch ointment; its route and safety information do not apply automatically to oral, injectable, otic or other preparations.

A Janus kinase inhibitor that modulates immune signaling. Zenrelia is labeled for allergic-dermatitis itching and atopic dermatitis in dogs at least twelve months old.

This combination pairs an insecticide with a macrocyclic lactone in a topical prescription preventive. Parasite coverage depends on the exact species-specific product; the brand family is not a guarantee of identical coverage.

A triazole antifungal with veterinary and human formulations. Itrafungol oral solution is labeled for Microsporum canis dermatophytosis in cats; Sporanox is a human itraconazole brand.

The two-ingredient Heartgard Plus combination is labeled for canine heartworm prevention and treatment/control of specified roundworms and hookworms. Prevention is different from treatment of established adult heartworm disease.

A nonsteroidal anti-inflammatory drug. This entry covers the ophthalmic Acular formulation; systemic oral and injectable products require separate product-specific prescribing assessment.

An antiseizure medication identified by the human brand Keppra. Veterinary seizure management requires a diagnosis, formulation-specific prescription and a plan for follow-up and emergencies.

A synthetic thyroid hormone used for hormone replacement. Thyro-Tabs Canine is labeled for replacement in dogs with diminished thyroid function.

Lokivetmab is a canine-targeted monoclonal antibody that blocks the itch-related cytokine IL-31. Cytopoint is a veterinarian-administered injectable immunotherapeutic for allergic and atopic dermatitis in dogs.

An H1 antihistamine identified by the Claritin brand. The cited tablet is labeled for human allergy symptoms; veterinary selection must account for the diagnosis, species and exact package.

Lotilaner is an isoxazoline used in prescription flea and tick products. Credelio and Credelio CAT are single-ingredient products with separate species-specific parasite and eligibility claims.

A fluoroquinolone antibacterial. Zeniquin is labeled for selected susceptible bacterial infections in dogs and cats.

Maropitant is a neurokinin-1 receptor antagonist used to prevent or treat vomiting under product-specific indications. Cerenia’s tablets and injection have different species, age and indication provisions.

An NSAID used in veterinary pain and inflammation management. In the United States, Metacam oral suspension is a canine product, while the injection has separate dog and cat labeling with materially different restrictions.

An antithyroid medication that reduces thyroid hormone synthesis. Felimazole coated tablets are labeled for feline hyperthyroidism; successful treatment needs biochemical and clinical monitoring.

A centrally acting muscle relaxant. Robaxin is a human prescription brand; veterinary treatment requires the veterinarian’s species-specific assessment.

A nitroimidazole antimicrobial active against specified anaerobic organisms and certain protozoa. The cited Flagyl label is human labeling; veterinary indication and formulation selection require separate clinical judgment.

Interceptor Plus combines heartworm prevention with labeled treatment/control of specified roundworms, hookworms, whipworms and tapeworms in dogs. Its parasite spectrum depends on the exact label and combination.

Mirataz is a mirtazapine transdermal ointment labeled for management of weight loss in cats. It can support a veterinarian’s nutrition plan but does not establish or treat every underlying cause of reduced intake.

A three-antibiotic ophthalmic ointment for susceptible superficial bacterial eye infections. This combination contains bacitracin and no corticosteroid; veterinary eye examination determines its appropriate use.

An antibiotic–corticosteroid ophthalmic combination. Unlike the bacitracin and gramicidin combinations, it contains a steroid, making diagnosis and screening before eye treatment particularly important.

A three-antibiotic ophthalmic solution used against susceptible superficial bacterial eye infections. Its ingredient identity is separate from the bacitracin ointment and the dexamethasone-containing combination.

An oral adult-flea treatment identified by the Capstar brand. It addresses adult fleas on the animal and does not replace an ongoing flea prevention and environmental management plan.

A topical antibiotic–antifungal–corticosteroid combination identified by Animax. Its label covers selected superficial skin and ear disorders in dogs and cats; it is not a single antibiotic or a sterile ophthalmic treatment.

Oclacitinib is a prescription Janus kinase inhibitor used to control allergic itch and atopic dermatitis in dogs meeting the label criteria. It reduces symptoms without identifying or removing the underlying allergy trigger.

A proton-pump inhibitor that suppresses gastric acid secretion. GastroGard is an equine veterinary formulation; Prilosec products are human formulations. Uses, administration and approved regimens must remain product-specific.

A serotonin 5-HT3 receptor antagonist used as an antiemetic. Human product labeling establishes the ingredient and warnings; animal prescribing requires an appropriate veterinary reference and individual assessment.

A sympathomimetic medication used in Proin for control of urinary incontinence caused by urethral sphincter hypotonus in dogs. It is not a general treatment for every cause of leaking or abnormal urination.

An inodilator used in selected canine cardiac disease. Vetmedin labeling must be matched to the patient’s diagnosis, disease stage and exact formulation.

Polysulfated glycosaminoglycan is a prescription joint medication. Adequan Canine is labeled to control signs of noninfectious degenerative or traumatic arthritis affecting canine synovial joints.

An insulin suspension for diabetic dogs and cats. Vetsulin provides replacement insulin and requires a patient-specific glucose-management plan.

The two-ingredient combination in U.S. Drontal tablets for cats and kittens treats specified tapeworms, hookworms and roundworms. Its label does not establish coverage of every intestinal parasite.

The three-ingredient combination in Drontal Plus provides labeled treatment of specified tapeworms, hookworms, roundworms and whipworms in dogs. The additional ingredient changes the combination and its product-specific precautions.

An alpha-adrenergic blocker that relaxes vascular smooth muscle. Minipress is a human antihypertensive brand; any veterinary use of the human capsules is extra-label and must be tied to the veterinarian’s diagnosis and prescription.

A glucocorticoid used for anti-inflammatory or immunosuppressive effects. Orapred and Pediapred are human prednisolone brands; use in animals is extra-label and depends on the disease, formulation and prescribing veterinarian’s plan.

Prednisone is a glucocorticoid that changes inflammatory and immune responses. Deltasone is a human oral brand-name reference; a veterinary plan depends on species, diagnosis, treatment duration and patient risks.

A nervous-system medication with distinct veterinary and human products. Bonqat is a feline oral solution for transportation- and veterinary-visit-related anxiety and fear. Lyrica is a human formulation; veterinary use of that product requires separate species-specific prescribing.

An insulin suspension used in ProZinc to reduce hyperglycemia and associated clinical signs in dogs and cats with diabetes mellitus. Insulin identity includes its formulation and concentration, not just the word insulin.

An anthelmintic found in multiple species-specific products. Strongid names a product family, not one universally interchangeable preparation.

A coxib-class NSAID. The cited US Onsior tablet label is for short-term postoperative pain and inflammation in eligible cats; it does not authorize an unrestricted chronic pain regimen.

A combination supplement marketed for liver support. Denamarin Advanced combines SAMe and a silybin complex; its use is supportive and does not establish the diagnosis or replace treatment for liver disease.

An isoxazoline ectoparasiticide. Simparica is a single-ingredient oral canine product for fleas and specified ticks.

A topical macrocyclic lactone used for selected parasite prevention and treatment. Revolution has dog and cat labeling, with parasite indications that differ by species.

A feline topical combination for selected fleas, ticks, mites, intestinal worms and heartworm prevention. The sarolaner component belongs to the isoxazoline class.

A gastrointestinal mucosal protectant associated with the Carafate brand. The human label covers duodenal ulcer treatment; a veterinarian determines the animal indication, administration plan and monitoring.

Sulfadimethoxine is a sulfonamide antimicrobial. The referenced Albon suspension is labeled for susceptible bacterial infections in dogs and cats and bacterial enteritis associated with coccidiosis in dogs.

An allylamine antifungal identified by the human Lamisil brand. Veterinary antifungal selection requires confirming the organism, infection site and appropriate formulation.

An aminoglycoside antibiotic. This entry covers the single-ingredient ophthalmic Tobrex product; systemic routes and combination products require separate identification.

An opioid analgesic with additional monoamine effects. Ultram is a human prescription brand; veterinary analgesic decisions require species-specific evidence and assessment.

A serotonin-modulating antidepressant identified in human labeling. Veterinary use requires a veterinarian-selected indication and regimen; the human depression label is not an animal treatment protocol.

An adrenal steroid-synthesis inhibitor. Vetoryl is labeled for pituitary-dependent and adrenal-dependent hyperadrenocorticism in dogs.

Ursodiol is a bile acid used in selected hepatobiliary treatment plans. Actigall is a human prescription product; its human gallstone indications do not establish a veterinary indication or a species-specific regimen.

A muscle-support supplement marketed by Virbac as URSOLYX. The manufacturer offers dog and cat soft-chew products and describes support for muscle function in aging, active or recuperating patients.

An SGLT2 inhibitor that increases urinary glucose loss. Senvelgo is labeled for selected diabetic cats that meet detailed eligibility and screening requirements.